Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARDS | AMGN | BMY | VRTX | GILD |
| Company | Aridis Pharmaceuticals Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.0001 | 275.81 | 58.57 | 454.72 | 92.59 |
| High | 0.0001 | 279.16 | 58.79 | 462.02 | 92.60 |
| Low | 0.0001 | 273.86 | 57.59 | 450.00 | 89.86 |
| Last | 0.0001 | 278.93 | 58.35 | 458.96 | 91.41 |
| Change | unch | +0.61 | -0.34 | +1.99 | -1.08 |
| % Change | unch | +0.22% | -0.58% | +0.44% | -1.17% |
| Volume | 4,250 | 2,036,570 | 4,798,264 | 660,045 | 4,228,547 |
| 20-Day Average Volume | 20,878 | 4,447,224 | 11,278,323 | 1,365,089 | 7,380,697 |
| Previous Close | 0.0001 | 278.32 | 58.69 | 456.97 | 92.49 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.0002 | 293.69 | 57.95 | 472.98 | 92.02 |
| 20-Day Raw Stochastic | 0.00% | 29.93% | 61.46% | 18.68% | 43.60% |
| 20-Day Relative Strength | 30.01% | 34.42% | 57.93% | 44.96% | 55.58% |
| Weighted Alpha | -55.91 | -4.27 | +24.72 | +21.33 | +24.93 |
| Today's Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 88% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 100% Buy | 8% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -50.00% since 11/08/24 | -0.40% since 11/26/24 | -0.68% since 11/26/24 | -1.73% since 11/26/24 | +0.35% since 11/26/24 |
| Low | 0.0001 on 12/04/24 | 273.86 on 12/04/24 | 57.59 on 12/04/24 | 451.05 on 12/04/24 | 89.86 on 12/04/24 |
| High | 0.0001 on 12/04/24 | 283.64 on 11/29/24 | 60.09 on 12/03/24 | 470.93 on 11/29/24 | 94.39 on 12/03/24 |
| 1-Month | |||||
| %Chg | -50.00% since 11/04/24 | -12.00% since 11/04/24 | +5.21% since 11/04/24 | -2.92% since 11/04/24 | +2.04% since 11/04/24 |
| Low | 0.0001 on 12/04/24 | 257.80 on 11/26/24 | 53.97 on 11/08/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 0.0003 on 11/07/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | unch since 07/31/24 | -15.65% since 09/04/24 | +16.77% since 09/04/24 | -4.09% since 09/04/24 | +15.85% since 09/04/24 |
| Low | 0.0001 on 12/04/24 | 257.80 on 11/26/24 | 47.55 on 09/09/24 | 445.00 on 11/21/24 | 77.74 on 09/05/24 |
| High | 0.0003 on 11/07/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -99.81% since 06/04/24 | -9.27% since 06/04/24 | +39.74% since 06/04/24 | -3.36% since 06/04/24 | +42.88% since 06/04/24 |
| Low | 0.0001 on 12/04/24 | 257.80 on 11/26/24 | 39.35 on 07/05/24 | 445.00 on 11/21/24 | 62.69 on 06/18/24 |
| High | 0.0800 on 07/03/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 5 | 149,606,192 | 119,033,712 | 117,683,024 | 115,267,136 |
| Shares Outstanding, K | 53,321 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 3,090,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -30,370,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 420,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -80,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 0.87 | 0.55 | 0.45 | 0.36 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 06/08/23 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 12/09/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.47 | 51.23 | 0.00 | 21.22 |